Searched for
KUNAL VALIA
RBI widens direct equity access for overseas investors, doubles investment limits under PISThe RBI has doubled investment limits for overseas individual investors under the Portfolio Investment Scheme and extended direct equity ac...- Debt funds: Is it time to exit long-duration bond funds as rate hike risks rise?The RBI’s rate-cut cycle is behind us. Experts foresee 50–75 bps of hikes. Your bond portfolio needs to reflect that.
- Planning to invest Rs 10 lakh overseas? Here are the markets to consider and how to do it rightFor global diversification, experts recommend a diversified, disciplined approach across regions.
- Investors turn to passive funds as active funds lagActive equity mutual funds have failed to beat their benchmark indices over the past year. This underperformance has revived the debate on ...
- Investors go active to passive, lap up more of smart beta fundsA series of new launches over the past one year led to assets under management (AUM) under this category surge to ₹29,322 crore in December...
- Popular mid-cap funds struggle to keep pace with runaway benchmark"With high inflows into mid-cap stocks over the last few years, market efficiency within mid-caps have improved a lot. This means that ther...
- No bias, no emotion; With quant funds the 'matrix' takes the callsQuant funds build a portfolio by selecting stocks on predetermined rules based on mathematical models. They use automated programs to enter...
- ETMarkets Smart Talk: We believe 2023 will be a year of accumulation for equities: Kunal ValiaThe Budget exercise has been positive for both equities and bonds as an asset class. From a macro perspective, the fiscal deficit estimate ...
- Kunal Valia highlights 6 factors working for India compared to global peers"The momentum is in favour of India as various macroeconomic parameters are stable while developed markets like the US and Europe have wide...
- Fastest rebound since 2003 invites skepticism for Indian stocksThe NSE Nifty 50 Index has surged more than 14% from a mid-June low as overseas investors turned buyers after months of withdrawals. That d...
- Focus on asset allocation in second half of 2022; inflation data to drive markets: Kunal Valia"The domestic IT sector had seen a strong run in 2020 and 2021 and some reversal was likely given the valuation. Further, domestic IT secto...
- Alpha an uphill struggle, mutual funds file for passive, factor fundsInvestors can soon choose from a wider bouquet of passive and factor funds as several fund houses including Navi Mutual Fund, Kotak MF and ...
- Buy Sun Pharmaceutical Industries, target Rs 455: Kunal BothraBuy Sun Pharmaceutical Industries Ltd. at a price target of Rs 455.0 and a stoploss at Rs 425 from entry point.
- Buy SPARC, price target Rs 190: Kunal BothraThe analyst suggested a stoploss at Rs 160.
- Buy Sun Pharmaceutical Industries, target Rs 458: Kunal BothraBuy Sun Pharmaceutical Industries Ltd. at a price target of Rs 458.0 and a stoploss at Rs 425 from entry point.
- Sell Sun Pharma, target Rs 565: Kunal BothraSell Sun Pharmaceutical Industries Ltd. at a price target of Rs 565.0 and a stoploss at Rs 600 from entry point.
- Buy Sun Pharmaceutical Industries, target Rs 640: Kunal BothraBuy Sun Pharmaceutical Industries Ltd. at a price target of Rs 640.0 and a stop loss at Rs 550 from entry point.
- Buy Sun Pharmaceutical Industries, target Rs 550: Kunal BothraBuy Sun Pharmaceutical Industries at a price target of Rs 550 and a stop loss at Rs 500 from entry point.
- Investors may stumble on hidden risks in credit opportunity fundsIn the last few months, mutual funds have been scrambling to cut exposure to companies with high debt. For instance, ICICI Prudential also ...
- Invest in credit funds when spreads are attractive over sovereign and high quality issuersMutual funds have been scrambling to cut exposure to companies with high debt. For instance, ICICI Prudential also cut its scheme’s holding...
Load More
